SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-19-001863
Filing Date
2019-07-10
Accepted
2019-07-10 10:14:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk1923270.htm SC 13D/A 46016
2 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 19636
3 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 17742
4 EXHIBIT 99.4 exhibit_99-4.htm EX-99.4 17813
5 image00002.jpg GRAPHIC 8620
  Complete submission text file 0001178913-19-001863.txt   114726
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Subject) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87987 | Film No.: 19948296
SIC: 2834 Pharmaceutical Preparations

Mailing Address AZRIELI CENTER, ROUND TOWER 22ND FLOOR TEL AVIV L3 67021
Business Address AZRIELI CENTER, ROUND TOWER 22ND FLOOR TEL AVIV L3 67021 972-3-607-0320
Capital Point Ltd. (Filed by) CIK: 0001634113 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13D/A